Good morning, everyone, and how are you today? A shiny day is unfolding over the Pharmalot corporate campus, where the short people are enjoying a respite from the school house thanks to the lingering effects of the recent storm. We will put them to work shortly. Meanwhile, we are preparing for the usual meetings and deadlines. We know you relate. So grab a cup of stimulation, or a water bottle if you prefer, and dig in. Here are some tidbits to get you started. Have a great day...
NPS Pharma Reports Trial Deaths And Stock Plunges (Bloomberg News)
Boehringer's Pradaxa Wins UK Backing For Stroke Prevention (Pharma Times)
Pharmasett Leads Race To Develop Oral Hep C Treatment (The Street)
Eisai Profit Hit As Aricept Sales Decline (Bloomberg News)
Exelixis Suffers Setback As FDA Rejects Prostate Cancer Trial Design (The Street)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr